carboxylic-acids-and-derivatives - carboxylic-acids-and-derivatives Manufacturer Supplier Exporter

Price

Supplier Type

Manufacturer
Trader
custom synthesis
Reagent
contract manufacturer

Supplier Region

Hyderabad(15)
Maharashtra(30)
Telangana(7)
Gujarat(19)
Uttar Pradesh(2)
Karnataka(2)
West Bengal(1)
Ahmedabad(2)
New Delhi(3)
Mumbai(15)
Haryana(1)
Delhi(5)
Vadodara(3)
Tamil Nadu(1)
Andhra Pradesh(3)
Madhya Pradesh(1)

Purity

United States Pharmacopeia (USP) Reference Standard
technical, ~90% (GC)
technical
tech. 90.00%
ReagentPlus?, ≥99%
ReagentPlus?, 99%
reagent grade, 97%
Pharmaceutical Secondary Standard
PESTANAL?, analytical standard
NLT 98%
hypergrade for LC-MS LiChrosolv?
for synthesis
for spectroscopy Uvasol?
for liquid chromatography LiChrosolv?
for gas chromatography MS SupraSolv?
for gas chromatography ECD and FID SupraSolv?
for analysis EMSURE? ACS,Reag. Ph Eur
for analysis EMSURE? ACS,ISO,Reag. Ph Eur
for analysis EMSURE? ACS
for analysis EMPARTA? ACS
European Pharmacopoeia (EP) Reference Standard
EMPLURA?
contaning 100ppm MEHQ inhibitor 99% (GC)
contaning 100ppm MEHQ inhibitor 98.00%
contains 50-100?ppm MEHQ as inhibitor, 98%
contains 250?ppm MEHQ as inhibitor, 99%
contains 10-20?ppm MEHQ as inhibitor, 99%
contains ≤30?ppm MEHQ as inhibitor, 99%
contains <200?ppm monomethyl ether hydroquinone as inhibitor, 98%
certified reference material, 1000?μg/mL in methanol
Certified Reference Material
C4-99.5% (GC)
C4-99% (GC)
C3-99.5% (GC)
C18-99%
British Pharmacopoeia (BP) Reference Standard
BioXtra, ≥99%
BioUltra, for molecular biology, ≥99.0%
BioUltra, for molecular biology, ~5?M in H2O
battery grade, ≥99%, acid <200 ppm, anhydrous
average Mn ~912
average Mn ~428
anhydrous, free-flowing, Redi-Dri?, ReagentPlus?, 99%
anhydrous, for analysis EMPLURA?
anhydrous, contains 200?ppm MEHQ as inhibitor, 99%
anhydrous powder, EMPROVE? ESSENTIAL, Ph. Eur., BP, JP, USP, FCC, E 330
anhydrous fine-granular, EMPROVE? ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, FCC, E 330
analytical standard
AldrichCPR
A.C.S. 99.5%
99.999%
99.9965%
99.995%
≥99.99% trace metals basis
99.99% trace metals basis
99.95% trace metals basis
99.9% trace metals basis
99.9%
99.80%
>99.8%(GC)
99.60%
99.53%
99.50%
>99.5%(GC)
99.5%
≥ 99.5%
99.5 to 102.5%
99.00%
>99.0%(T)
>99.0%(GC)(T)
>99.0%(GC)
99.0%
99.0 to 102.0%
99%+
99%, contains ≤100?ppm monomethyl ether hydroquinone as inhibitor
99%, 25 Kilograms
99%, 1
99% HPLC
99% and above
>99%
99%
≥99%
99 atom % 13C
99
98+%
98+
98.50%
98.00%
>98.0%(T)(HPLC)
>98.0%(T)
>98.0%(HPLC)
>98.0%(GC)(T)
>98.0%(GC)
≥98.0% (GC)
98%+
≥98% palmitic acid basis (GC)
≥98% (HPLC)
98%
≥98%
97.00%
>97.0%(T)
>97.0%(GC)(T)
>97.0%(GC)
≥97.0%
≥97% (titration)
≥97%
97%
96.56
>96.0%(GC)
96.0%
96%
95.00%
>95.0%(T)(HPLC)
>95.0%(T)
>95.0%(GC)(T)
>95.0%(GC)
≥95.0% (GC)
95%+
≥95%
95%
>93.0%(GC)
>90.0%(GC)
90%
90 % Above
88%
86.50%
85-90%
85%
25 Kilograms
100%
1 Dram
(stabilised) for synthesis
(stabilised with hydroquinone monomethyl ether) for synthesis
(mixture of isomeres) for synthesis
(mixture of di-and triisocyanates) for synthesis
(mixture of cis- and trans isomers) for synthesis
&le
&ge